Case of hemorrhagic shock due to hypermenorrhea during anticoagulant therapy.
We report the case of a patient with uterine myoma who developed uncontrollable massive hemorrhage from the uterus during anticoagulant therapy after cardiac valve replacement and required hysterectomy. There was a discrepancy between the laboratory findings regarding the blood coagulation system and the clinical manifestations, suggesting a combination of multiple factors, such as a hormonal imbalance. This was a case that demanded strict attention to the management of the uterine lesions during the conduct of anticoagulant treatment.
Minakuchi
K
K
Department of Obstetrics and Gynecology, Osaka City University Medical School, Japan.
Hirai
K
K
Kawamura
N
N
Ishiko
O
O
Kanaoka
Y
Y
Ogita
S
S
D000925:Anticoagulants / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007044:Hysterectomy; D007889:Leiomyoma / Q000150:complications / Q000473:pathology / Q000601:surgery; D008595:Menorrhagia / Q000139:chemically induced* / Q000150:complications* / Q000601:surgery; D008875:Middle Aged; D008944:Mitral Valve Insufficiency / Q000188:drug therapy / Q000601:surgery; D012771:Shock, Hemorrhagic / Q000209:etiology*; D014594:Uterine Neoplasms / Q000150:complications / Q000473:pathology / Q000601:surgery
D000925:Anticoagulants